Secular trends in baseline characteristics, treatment retention, and response rates in 27 189 bionaïve axial spondyloarthritis patients initiating tumour necrosis factor inhibitor: Results from the EuroSpA collaboration

Sara Nysom  Christiansen; Lykke Midtbøll Ørnbjerg; Simon Horskjær Rasmussen; AG Loft; Mikkel Østergaard; Merete Lund Hetland

Secular trends in baseline characteristics, treatment retention, and response rates in 27 189 bionaïve axial spondyloarthritis patients initiating tumour necrosis factor inhibitor: Results from the EuroSpA collaboration

Sara Nysom Christiansen, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, AG Loft, Mikkel Østergaard, Merete Lund Hetland

Department for Rheumatology and Spine Diseases

Original language	English
Article number	PP65
Book series	Scandinavian Journal of Rheumatology, Supplement
Volume	50
Issue number	130
Pages (from-to)	72-3
Number of pages	2
ISSN	0301-3847
Publication status	Published - 2021

Cite this

Christiansen, S. N., Ørnbjerg, L. M., Rasmussen, S. H., Loft, AG., Østergaard, M., & Hetland, M. L. (2021). Secular trends in baseline characteristics, treatment retention, and response rates in 27 189 bionaïve axial spondyloarthritis patients initiating tumour necrosis factor inhibitor: Results from the EuroSpA collaboration. Scandinavian Journal of Rheumatology, Supplement, 50(130), 72-3. Article PP65.

Secular trends in baseline characteristics, treatment retention, and response rates in 27 189 bionaïve axial spondyloarthritis patients initiating tumour necrosis factor inhibitor: Results from the EuroSpA collaboration. / Christiansen, Sara Nysom ; Ørnbjerg, Lykke Midtbøll; Rasmussen, Simon Horskjær et al.
In: Scandinavian Journal of Rheumatology, Supplement, Vol. 50, No. 130, PP65, 2021, p. 72-3.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Christiansen, SN , Ørnbjerg, LM, Rasmussen, SH, Loft, AG, Østergaard, M & Hetland, ML 2021, 'Secular trends in baseline characteristics, treatment retention, and response rates in 27 189 bionaïve axial spondyloarthritis patients initiating tumour necrosis factor inhibitor: Results from the EuroSpA collaboration', Scandinavian Journal of Rheumatology, Supplement, vol. 50, no. 130, PP65, pp. 72-3.

Christiansen SN , Ørnbjerg LM, Rasmussen SH, Loft AG, Østergaard M , Hetland ML. Secular trends in baseline characteristics, treatment retention, and response rates in 27 189 bionaïve axial spondyloarthritis patients initiating tumour necrosis factor inhibitor: Results from the EuroSpA collaboration. Scandinavian Journal of Rheumatology, Supplement. 2021;50(130):72-3. PP65.

Christiansen, Sara Nysom ; Ørnbjerg, Lykke Midtbøll ; Rasmussen, Simon Horskjær et al. / Secular trends in baseline characteristics, treatment retention, and response rates in 27 189 bionaïve axial spondyloarthritis patients initiating tumour necrosis factor inhibitor: Results from the EuroSpA collaboration. In: Scandinavian Journal of Rheumatology, Supplement. 2021 ; Vol. 50, No. 130. pp. 72-3.

@article{be5e7d0fd7684ecb9b00d0eb1d1a63fe,

title = "Secular trends in baseline characteristics, treatment retention, and response rates in 27 189 biona{\"i}ve axial spondyloarthritis patients initiating tumour necrosis factor inhibitor: Results from the EuroSpA collaboration",

author = "Christiansen, {Sara Nysom} and {\O}rnbjerg, {Lykke Midtb{\o}ll} and Rasmussen, {Simon Horskj{\ae}r} and AG Loft and Mikkel {\O}stergaard and Hetland, {Merete Lund}",

note = "COPECARE",

year = "2021",

language = "English",

volume = "50",

pages = "72--3",

journal = "Scandinavian Journal of Rheumatology, Supplement",

issn = "0301-3847",

publisher = "Taylor & Francis A B",

number = "130",

}

TY - ABST

T1 - Secular trends in baseline characteristics, treatment retention, and response rates in 27 189 bionaïve axial spondyloarthritis patients initiating tumour necrosis factor inhibitor: Results from the EuroSpA collaboration

AU - Christiansen, Sara Nysom

AU - Ørnbjerg, Lykke Midtbøll

AU - Rasmussen, Simon Horskjær

AU - Loft, AG

AU - Østergaard, Mikkel

AU - Hetland, Merete Lund

N1 - COPECARE

PY - 2021

Y1 - 2021

M3 - Conference abstract in journal

SN - 0301-3847

VL - 50

SP - 72

EP - 73

JO - Scandinavian Journal of Rheumatology, Supplement

JF - Scandinavian Journal of Rheumatology, Supplement

IS - 130

M1 - PP65

ER -